input_term,has_context,match_1,score_1,match_2,score_2,match_3,score_3,match_4,score_4,match_5,score_5
25-30% DUCTAL COMPONENT,Yes,Prostate Ductal Adenocarcinoma,10.0,Breast Ductal Adenoma,10.0,Breast Ductal Hyperplasia,10.0,Breast Ductal Carcinoma,10.0,Pancreatic Ductal Adenocarcinoma,10.0
AB,Yes,Paratesticular Rhabdomyoma,50.0,Cervical Rhabdomyoma,50.0,Vaginal Rhabdomyoma,50.0,Vulvar Rhabdomyoma,50.0,Genital Rhabdomyoma,50.0
ACANTHOLYTIC,Yes,Acantholytic Acanthoma,65.0,Laryngeal Acantholytic Squamous Cell Carcinoma,56.0,Skin Acantholytic Squamous Cell Carcinoma,56.0,"Breast Squamous Cell Carcinoma, Acantholytic Variant",55.0,,0.0
ACC,Yes,Benign Accessory Urethral Gland Neoplasm,50.0,Accessory Urethral Gland Adenocarcinoma,50.0,Malignant Accessory Urethral Gland Neoplasm,50.0,Accessory Urethral Gland Neoplasm,50.0,Accessory Nerve Neoplasm,50.0
ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES,Yes,Acute Myeloid Leukemia,55.0,Myeloid Leukemia,50.0,Leukemia,45.0,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",25.0,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",25.0
ACYC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ADENOCARINOMA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
AMELANOTIC NODULAR,Yes,"Ganglioneuroblastoma, Nodular",15.0,Nodular Hidradenoma,15.0,Nodular Fasciitis,15.0,Nodular Melanoma,15.0,Amelanotic Melanoma,15.0
AML WITH BIALLELIC MUTATIONS OF CEBPA,Yes,Acute Myeloid Leukemia with Biallelic CEBPA Mutation,10.0,Acute Myeloid Leukemia with CEBPA Mutation,6.0,Myelodysplastic Syndrome with Biallelic TP53 Mutation,6.0,Myelodysplastic Syndrome with Biallelic TP53 Inactivation,6.0,Acute Myeloid Leukemia with Germline CEBPA Mutation,5.0
AML WITH MUTATED CEBPA,Yes,Myeloid Neoplasm with Mutated TP53,7.5,Myelodysplastic Syndrome with Mutated TP53,7.5,Myelodysplastic Syndrome with Mutated SF3B1,7.5,ELOC-Mutated Renal Cell Carcinoma,6.0,Acute Myeloid Leukemia with Mutated TP53,6.0
AML WITH MUTATED NPM1,Yes,Myeloid Neoplasm with Mutated TP53,7.5,Myelodysplastic Syndrome with Mutated TP53,7.5,Myelodysplastic Syndrome with Mutated SF3B1,7.5,ELOC-Mutated Renal Cell Carcinoma,6.0,Acute Myeloid Leukemia with Mutated TP53,6.0
AML WITH MUTATED RUNX1,Yes,Myeloid Neoplasm with Mutated TP53,7.5,Myelodysplastic Syndrome with Mutated TP53,7.5,Myelodysplastic Syndrome with Mutated SF3B1,7.5,ELOC-Mutated Renal Cell Carcinoma,6.0,Acute Myeloid Leukemia with Mutated TP53,6.0
AML WITH MYELODYSPLASIA-RELATED CHANGES,Yes,"Acute Myeloid Leukemia, Myelodysplasia-Related",12.0,"Refractory Acute Myeloid Leukemia, Myelodysplasia-Related",10.0,"Recurrent Acute Myeloid Leukemia, Myelodysplasia-Related",10.0,Acute Myeloid Leukemia with Myelodysplasia-Related Cytogenetic Abnormalities,8.57,Acute Myeloid Leukemia with Myelodysplasia-Related Gene Mutations,8.57
"AML, NOS",Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA,Yes,Lymphoma,50.0,Intestinal T-Cell Lymphoma,20.0,Hepatosplenic T-Cell Lymphoma,20.0,Mantle Cell Lymphoma,20.0,"NK-Cell Lymphoma, Unclassifiable",20.0
ANSC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
APAD,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
APL WITH PML-RARA,Yes,Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,8.57,Recurrent Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,7.5,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,7.5,Adult Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA,7.5,Acute Myeloid Leukemia with STAT3-RARA,6.0
ASPS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ASTROCYTOMA_GRADE_III-IV,Yes,Astrocytoma,40.0,,0.0,,0.0,,0.0,,0.0
ATL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
"ATYPICAL CHRONIC MYELOID LEUKAEMIA, BCR-ABL1 NEGATIVE",Yes,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",17.14,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",17.14,"Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive",17.14,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",17.14,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",17.14
"ATYPICAL CHRONIC MYELOID LEUKEMIA, BCR-ABL1-",Yes,Atypical Chronic Myeloid Leukemia,60.0,Myeloid Leukemia,50.0,Leukemia,45.0,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",25.0,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",21.43
ATYPICAL LUNG CARCINOID,Yes,Atypical Adenomatous Lung Hyperplasia,15.0,Atypical Polypoid Adenomyoma,10.0,Strumal Carcinoid,10.0,Breast Atypical Papilloma,10.0,Breast Atypical Myoepitheliosis,10.0
B-CELL_ALL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
BASALOID PENILE SQUAMOUS CELL CARCINOMA,Yes,Penile Squamous Cell Carcinoma,64.0,Squamous Cell Carcinoma,58.0,Carcinoma,46.0,Penile Basaloid Squamous Cell Carcinoma,30.0,Metastatic Penile Squamous Cell Carcinoma,24.0
BENIGN PT,Yes,Benign Ameloblastoma,15.0,Benign Meningioma,15.0,Benign Mastocytoma,15.0,Benign Myoepithelioma,15.0,Benign PEComa,15.0
BILIARY TRACT CANCER,Yes,Biliary Tract Carcinoma,20.0,Metastatic Biliary Tract Carcinoma,15.0,Advanced Biliary Tract Carcinoma,15.0,Unresectable Biliary Tract Carcinoma,15.0,Refractory Biliary Tract Carcinoma,15.0
"BILIARY TRACT CANCER, NOS",Yes,Biliary Tract Carcinoma,20.0,Metastatic Biliary Tract Carcinoma,15.0,Advanced Biliary Tract Carcinoma,15.0,Unresectable Biliary Tract Carcinoma,15.0,Refractory Biliary Tract Carcinoma,15.0
"BLADDER/URINARY TRACT CANCER, NOS",Yes,Benign Urinary Tract Neoplasm,15.0,Squamous Papilloma of the Urinary Tract,15.0,Villous Adenoma of the Urinary Tract,15.0,Urinary Tract Carcinoma,15.0,Adenocarcinoma of the Urinary Tract,15.0
BLAST_PHASE_CHRONIC_MYELOID_LEUKAEMIA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
BLCA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
BLOOD CANCER,Yes,Stage D Prostate Cancer,10.0,Stage B Prostate Cancer,10.0,Stage A Prostate Cancer,10.0,Stage C Prostate Cancer,10.0,Uterine Corpus Cancer,10.0
"BLOOD CANCER, NOS",Yes,Stage D Prostate Cancer,10.0,Stage B Prostate Cancer,10.0,Stage A Prostate Cancer,10.0,Stage C Prostate Cancer,10.0,Uterine Corpus Cancer,10.0
BORDERLINE PT,Yes,Borderline Cystadenoma,15.0,Borderline Serous Cystadenofibroma,10.0,Borderline Papillary Cystadenoma,10.0,Borderline Serous Cystadenoma,10.0,Borderline Phyllodes Tumor,10.0
BRCA,Yes,BRCA-Associated Ovarian Carcinoma,57.5,BRCA-Associated Breast Carcinoma,57.5,BRCA-Associated Malignant Neoplasm,57.5,Recurrent BRCA- Associated Ovarian Carcinoma,56.0,Metastatic BRCA-Associated Breast Carcinoma,56.0
BRCA_LUMA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
BRCA_LUMB,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
BRCA_NORMAL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
"BREAST INVASIVE CARCINOSARCOMA, NOS",Yes,Carcinosarcoma,50.0,Sarcoma,40.0,Invasive Breast Carcinoma,20.0,Invasive Breast Papillary Carcinoma,15.0,Invasive Breast Micropapillary Carcinoma,15.0
BREAST INVASIVE DUCTAL CARCINOMA,Yes,Carcinoma,47.5,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,24.0,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,24.0,Breast Ductal Carcinoma In Situ,22.5,Invasive Breast Papillary Carcinoma,22.5
BRONCHIOALVEOLAR_CARCINOMA,Yes,Carcinoma,40.0,,0.0,,0.0,,0.0,,0.0
BRONCHIOLOALVEOLAR_ADENOCARCINOMA,Yes,Carcinoma,40.0,Adenocarcinoma,40.0,,0.0,,0.0,,0.0
B_CELL_MEDIASTINAL_LARGE,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CANCER OF UNKNOWN PRIMARY,Yes,Adenocarcinoma of Unknown Primary,20.0,Carcinoma of Unknown Primary,20.0,Melanoma of Unknown Primary,20.0,Neuroendocrine Carcinoma of Unknown Primary,15.0,Resectable Carcinoma of Unknown Primary,15.0
"CANCER OF UNKNOWN PRIMARY, NOS",Yes,Adenocarcinoma of Unknown Primary,20.0,Carcinoma of Unknown Primary,20.0,Melanoma of Unknown Primary,20.0,Neuroendocrine Carcinoma of Unknown Primary,15.0,Resectable Carcinoma of Unknown Primary,15.0
CARCINOID,Yes,Strumal Carcinoid,65.0,Appendix Tubular Carcinoid,60.0,Gallbladder Tubular Carcinoid,60.0,Combined Carcinoid and Adenocarcinoma,60.0,Laryngeal Carcinoid Tumor,60.0
CARCINOID TUMOR,Yes,Laryngeal Carcinoid Tumor,70.0,Ovarian Teratoma with Carcinoid Tumor,65.0,Ovarian Insular Carcinoid Tumor,65.0,Ovarian Trabecular Carcinoid Tumor,65.0,Ovarian Mucinous Carcinoid Tumor,65.0
CARCINOID-ENDOCRINE TUMOUR,Yes,Strumal Carcinoid,10.0,Reproductive Endocrine Neoplasm,10.0,Endocrine Neoplasm,10.0,Childhood Endocrine Neoplasm,10.0,Benign Endocrine Neoplasm,10.0
CARCINOMA WITH SQUAMOUS DIFFERENTIATION,Yes,Invasive Urothelial Carcinoma with Squamous Differentiation,68.0,Invasive Bladder Urothelial Carcinoma with Squamous Differentiation,65.0,Invasive Ureter Urothelial Carcinoma with Squamous Differentiation,65.0,Ovarian Endometrioid Adenocarcinoma with Squamous Differentiation,62.0,Carcinoma,50.0
CARCINOSARCOMA-MAMMARY GLAND,Yes,Carcinosarcoma,50.0,Sarcoma,40.0,Parotid Gland Carcinosarcoma,20.0,Salivary Gland Carcinosarcoma,20.0,Lacrimal Gland Carcinosarcoma,20.0
CARCINOSARCOMA-MAMMARY GLAND; BREAST,Yes,Carcinosarcoma,47.5,Sarcoma,40.0,Vulvar Adenocarcinoma of Mammary Gland Type,15.0,Parotid Gland Carcinosarcoma,15.0,Salivary Gland Carcinosarcoma,15.0
CCOV,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CESC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CESC_SQUAMOUSCARCINOMA,Yes,Carcinoma,40.0,,0.0,,0.0,,0.0,,0.0
CHOL EXTRA,Yes,Extra-Adrenal Paraganglioma,10.0,Metastatic Extra-Adrenal Paraganglioma,7.5,Extra-Adrenal Sympathetic Paraganglioma,7.5,Extra-Adrenal Retroperitoneal Paraganglioma,7.5,,0.0
CHOLANGIOCARCINOMA; DISTAL,Yes,Cholangiocarcinoma,55.0,Carcinoma,40.0,Advanced Cholangiocarcinoma,15.0,Metastatic Cholangiocarcinoma,15.0,Unresectable Cholangiocarcinoma,15.0
CHRONIC MYELOGENOUS LEUKEMIA,Yes,Philadelphia Chromosome Negative BCR-ABL1 Negative Chronic Myelogenous Leukemia,61.25,Leukemia,50.0,Refractory Chronic Leukemia,20.0,Recurrent Chronic Leukemia,20.0,Chronic Leukemia,20.0
"CHRONIC MYELOID LEUKEMIA, BCR-ABL1+",Yes,"Chronic Myeloid Leukemia, BCR-ABL1 Positive",75.0,"Meningeal Chronic Myeloid Leukemia, BCR-ABL1 Positive",71.43,"Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive",71.43,"Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive",71.43,"Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive",71.43
CHRONIC_MYELOID_LEUKAEMIA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CLASSICAL HCA,Yes,Classical Glioblastoma,15.0,Classical Burkitt Lymphoma,10.0,Classical Low Grade Fibromyxoid Sarcoma,6.0,,0.0,,0.0
CLEAR CELL PAPILLARY RENAL CELL CARCINOMA,Yes,Papillary Renal Cell Carcinoma,64.0,Renal Cell Carcinoma,58.0,Carcinoma,46.0,Advanced Papillary Renal Cell Carcinoma,24.0,Advanced Clear Cell Renal Cell Carcinoma,24.0
CML,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CNS,Yes,Childhood Acute Lymphoblastic Leukemia CNS 1 Toronto Guidelines v2,54.29,Childhood Acute Lymphoblastic Leukemia CNS 2 Toronto Guidelines v2,54.29,Childhood Acute Lymphoblastic Leukemia CNS 3 Toronto Guidelines v2,54.29,Childhood Acute Lymphoblastic Leukemia CNS-Negative Toronto Guidelines v2,53.75,Childhood Acute Lymphoblastic Leukemia CNS-Positive Toronto Guidelines v2,53.75
CNS CANCER,Yes,Stage D Prostate Cancer,10.0,Stage B Prostate Cancer,10.0,Stage A Prostate Cancer,10.0,Stage C Prostate Cancer,10.0,Uterine Corpus Cancer,10.0
COAD,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
COAD_GS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
COLON ADENOCARCINOMA IN SITU,Yes,Colon Adenocarcinoma,60.0,Adenocarcinoma In Situ,60.0,Adenocarcinoma,50.0,Carcinoma In Situ,50.0,Carcinoma,40.0
COLORECTAL HYPERMUTATED,Yes,Hypermutated Colorectal Carcinoma,20.0,Colorectal Leiomyoma,15.0,Colorectal Lipoma,15.0,Colorectal Leiomyosarcoma,15.0,Colorectal Sarcoma,15.0
CONGENITAL FIBROSARCOMA,Yes,Fibrosarcoma,55.0,Sarcoma,40.0,Ovarian Fibrosarcoma,15.0,Kidney Fibrosarcoma,15.0,Breast Fibrosarcoma,15.0
CRC HM,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CSCC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
CUTANEOUS MALIGNANCY OF HAIR MATRIX CELLS,Yes,Testicular Teratoma with Somatic-Type Malignancy,6.0,Testicular Seminoma with Syncytiotrophoblastic Cells,6.0,Penile Cutaneous Melanoma,6.0,Ovarian Dermoid Cyst with Somatic-Type Malignancy,6.0,Cutaneous Merkel Cell Carcinoma,6.0
DEDIFFERENTIATED,Yes,Dedifferentiated Chordoma,65.0,Dedifferentiated Chondrosarcoma,65.0,Dedifferentiated Leiomyosarcoma,65.0,Dedifferentiated Liposarcoma,65.0,Ovarian Dedifferentiated Carcinoma,60.0
DERMATOFIBROMA,Yes,Fibroma,40.0,,0.0,,0.0,,0.0,,0.0
DUCTAL/NST,Yes,Prostate Ductal Adenocarcinoma,10.0,Breast Ductal Adenoma,10.0,Breast Ductal Hyperplasia,10.0,Breast Ductal Carcinoma,10.0,Pancreatic Ductal Adenocarcinoma,10.0
EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA,Yes,Leukemia,46.0,Early T Precursor Acute Lymphoblastic Leukemia,24.0,Early T Precursor Lymphoblastic Leukemia/Lymphoma,24.0,Early T Precursor Acute Lymphoblastic Leukemia with BCL11B Rearrangement,17.14,"Early T Precursor Acute Lymphoblastic Leukemia, Not Otherwise Specified",15.0
EMBRYONAL TUMOR WITH ABUNDANT NEUROPIL AND TRUE ROSETTES,Yes,Embryonal Tumor with Multilayered Rosettes,15.0,"Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated",15.0,Stage M0 Embryonal Tumor with Multilayered Rosettes,15.0,Stage M1 Embryonal Tumor with Multilayered Rosettes,15.0,Stage M2 Embryonal Tumor with Multilayered Rosettes,15.0
EMBT,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ENDOCERVICAL ADENOCARCINOMA OF THE USUAL TYPE,Yes,Cervical Adenocarcinoma,50.0,Adenocarcinoma,50.0,Carcinoma,40.0,"Endocervical Adenocarcinoma, Usual-Type",30.0,"Recurrent Endocervical Adenocarcinoma, Usual-Type",22.5
EPENDYMOBLASTOMA,Yes,Blastoma,40.0,,0.0,,0.0,,0.0,,0.0
EPITHELIOID CELL TUMOR,Yes,Juxtaglomerular Cell Tumor,20.0,Epithelioid Trophoblastic Tumor,20.0,Leydig Cell Tumor,20.0,Granulosa Cell Tumor,20.0,Sertoli Cell Tumor,20.0
ESCA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ESCA_GS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ESOPHAGUS/STOMACH,Yes,Thoracic Esophagus Adenocarcinoma,10.0,Cervical Esophagus Adenocarcinoma,10.0,Distal Esophagus Adenocarcinoma,10.0,Intraepithelial Neoplasia in Barrett Esophagus,7.5,Unresectable Distal Esophagus Adenocarcinoma,7.5
ETMR,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ETP-ALL,Yes,Mature T-ALL,15.0,Pre T-ALL,15.0,,0.0,,0.0,,0.0
EWING-LIKE SARCOMA,Yes,Sarcoma,50.0,Vulvar Ewing Sarcoma,20.0,Kidney Ewing Sarcoma,20.0,Sinonasal Ewing Sarcoma,20.0,Skin Ewing Sarcoma,20.0
EXTRA-ADRENAL PHEOCHROMOCYTOMA,Yes,Extra-Adrenal Paraganglioma,20.0,Adrenal Gland Pheochromocytoma,20.0,Childhood Adrenal Gland Pheochromocytoma,15.0,Advanced Adrenal Gland Pheochromocytoma,15.0,Metastatic Extra-Adrenal Paraganglioma,15.0
EXTRAHEPATIC CHOLANGIOCARCINOMA,Yes,Cholangiocarcinoma,55.0,Carcinoma,40.0,Advanced Cholangiocarcinoma,15.0,Metastatic Cholangiocarcinoma,15.0,Unresectable Cholangiocarcinoma,15.0
"FOLLICULAR, PAPILLARY",Yes,Papillary Adenofibroma,15.0,Papillary Craniopharyngioma,15.0,Follicular Ameloblastoma,15.0,Papillary Ependymoma,15.0,Papillary Meningioma,15.0
GINET,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
"GLIOBLASTOMA, IDH-MUTANT",Yes,Glioblastoma,50.0,Blastoma,40.0,"Glioblastoma, IDH-Wildtype",20.0,"Astrocytoma, IDH-Mutant",20.0,"Recurrent Glioblastoma, IDH-Wildtype",15.0
GLIONEURONAL TUMOR,Yes,Myxoid Glioneuronal Tumor,70.0,Papillary Glioneuronal Tumor,70.0,Recurrent Myxoid Glioneuronal Tumor,65.0,Rosette-Forming Glioneuronal Tumor,65.0,Diffuse Leptomeningeal Glioneuronal Tumor,65.0
GLOMANGIOSARCOMA,Yes,Angiosarcoma,40.0,Sarcoma,40.0,,0.0,,0.0,,0.0
HEAD & NECK SQUAMOUS CELL CARCINOMA BASALOID TYPE,Yes,Squamous Cell Carcinoma,55.0,Carcinoma,45.0,Head and Neck Basaloid Squamous Cell Carcinoma,30.0,Recurrent Head and Neck Squamous Cell Carcinoma,25.0,Refractory Head and Neck Squamous Cell Carcinoma,25.0
HEAD AND NECK CARCINOMA OTHER,Yes,Head and Neck Carcinoma,70.0,Neck Carcinoma,60.0,Carcinoma,50.0,Head and Neck Neuroendocrine Carcinoma,22.5,Recurrent Head and Neck Carcinoma,22.5
"HEAD AND NECK CARCINOMA, OTHER",Yes,Head and Neck Carcinoma,70.0,Neck Carcinoma,60.0,Carcinoma,50.0,Head and Neck Neuroendocrine Carcinoma,22.5,Recurrent Head and Neck Carcinoma,22.5
HEAD AND NECK SQUAMOUS CELL CARCINOMA OF UNKNOWN PRIMARY,Yes,Neck Squamous Cell Carcinoma of Unknown Primary,65.71,Head and Neck Squamous Cell Carcinoma,61.43,Squamous Cell Carcinoma of Unknown Primary,61.43,Carcinoma of Unknown Primary,52.86,Squamous Cell Carcinoma,52.86
HEMANGIOPERICYTOMA OF THE CENTRAL NERVOUS SYSTEM,Yes,Hemangiopericytoma,47.5,Central Nervous System Paraganglioma,22.5,Central Nervous System Neuroblastoma,22.5,Central Nervous System Ganglioneuroblastoma,22.5,Central Nervous System Leukemia,22.5
HEPATOBILIARY CANCER,Yes,Hepatobiliary Neoplasm,15.0,Stage D Prostate Cancer,10.0,Stage B Prostate Cancer,10.0,Stage A Prostate Cancer,10.0,Stage C Prostate Cancer,10.0
HGGNOS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
HNSC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
HURTHLE,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
HYPOPHARYNGEAL,Yes,Hypopharyngeal Neoplasm,65.0,Hypopharyngeal Carcinoma,65.0,Benign Hypopharyngeal Neoplasm,60.0,Malignant Hypopharyngeal Neoplasm,60.0,Recurrent Hypopharyngeal Carcinoma,60.0
IDC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
INFANTILE SARCOMA,Yes,Sarcoma,55.0,Vaginal Sarcoma,15.0,Ovarian Sarcoma,15.0,Vulvar Sarcoma,15.0,Prostate Sarcoma,15.0
INFILTRATING DUCTAL & LOBULAR,Yes,Breast Mixed Ductal and Lobular Carcinoma,12.0,Invasive Breast Ductal Carcinoma and Lobular Carcinoma,12.0,Invasive Breast Ductal Carcinoma and Invasive Lobular Carcinoma,12.0,Breast Ductal Carcinoma In Situ and Lobular Carcinoma,12.0,Breast Ductal Carcinoma In Situ and Lobular Carcinoma In Situ,12.0
INFILTRATING DUCTAL CARCINOMA,Yes,Carcinoma,50.0,Breast Ductal Carcinoma,20.0,Breast Ductal Carcinoma In Situ,15.0,Metastatic Breast Ductal Carcinoma,15.0,Squamoid Eccrine Ductal Carcinoma,15.0
INITIAL CNS TUMOR,Yes,Metanephric Tumor,10.0,Metanephric Stromal Tumor,10.0,Juxtaglomerular Cell Tumor,10.0,Adrenal Rest Tumor,10.0,Paratesticular Adenomatoid Tumor,10.0
INVASIVE_DUCTAL_CARCINOMA,Yes,Carcinoma,40.0,,0.0,,0.0,,0.0,,0.0
KICH,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
KIRC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
KIRP,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LAML,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LGSOC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LIHB,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LIHC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LIPOFIBROMATOSIS-LIKE NEURAL TUMOR,Yes,Lipofibromatosis,47.5,Fibroma,40.0,Fibromatosis,40.0,Vulvar Lipoblastoma-Like Tumor,15.0,Enterochromaffin-Like Cell Neuroendocrine Tumor G1,12.0
"LIVER CANCER, NOS",Yes,Stage I Liver Cancer,20.0,Stage II Liver Cancer,20.0,Stage IV Liver Cancer,20.0,Liver Leiomyoma,15.0,Liver Lipoma,15.0
LIVER TUMOR,Yes,Liver Neuroendocrine Tumor G1,20.0,Liver Neuroendocrine Tumor G3,20.0,Liver Neuroendocrine Tumor G2,20.0,Liver Neuroendocrine Tumor,20.0,Metanephric Tumor,15.0
LIVER_CANCER,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LNET,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LOW HYPODIPLOID,Yes,Low-Hypodiploid B Acute Lymphoblastic Leukemia,12.0,Low Grade Glioma,10.0,Low Grade Astrocytoma,10.0,Low-CSD Melanoma,10.0,Low Grade Osteosarcoma,10.0
LOW-GRADE NEUROEPITHELIAL TUMOR,Yes,Polymorphous Low Grade Neuroepithelial Tumor of the Young,20.0,Recurrent Polymorphous Low Grade Neuroepithelial Tumor of the Young,17.14,Recurrent Low Grade Glioma,15.0,Recurrent Low Grade Astrocytoma,15.0,Childhood Low Grade Glioma,15.0
LUAD,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS,Yes,Carcinoma,47.5,Prostate Carcinoma Metastatic in the Lung,15.0,Recurrent Breast Mucinous Carcinoma,15.0,Metastatic Breast Carcinoma in the Lung,15.0,Breast Mucinous Carcinoma,15.0
LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS,Yes,Carcinoma,47.5,Prostate Carcinoma Metastatic in the Lung,15.0,Metastatic Breast Carcinoma in the Lung,15.0,Advanced Lung Neuroendocrine Carcinoma,15.0,Metastatic Lung Neuroendocrine Carcinoma,15.0
LUNG CARCINOID,Yes,Strumal Carcinoid,15.0,Lung Meningioma,15.0,Lung Neoplasm,15.0,Lung Adenofibroma,15.0,Lung Myoepithelioma,15.0
LUNG NEUROENDOCRINE,Yes,Lung Neuroendocrine Carcinoma,70.0,Lung Neuroendocrine Tumor G1,70.0,Lung Neuroendocrine Tumor,70.0,Lung Neuroendocrine Tumor G2,70.0,Lung Neuroendocrine Neoplasm,70.0
LUNG NEUROENDOCRINE TUMOR,Yes,Lung Neuroendocrine Tumor,100.0,Lung Neuroendocrine Tumor G1,80.0,Lung Neuroendocrine Tumor G2,80.0,Advanced Lung Neuroendocrine Tumor,72.5,Metastatic Lung Neuroendocrine Tumor,72.5
LUNG_CARCINOID,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
LUSC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
"LYMPHATIC CANCER, NOS",Yes,Stage D Prostate Cancer,10.0,Stage B Prostate Cancer,10.0,Stage A Prostate Cancer,10.0,Stage C Prostate Cancer,10.0,Uterine Corpus Cancer,10.0
M0,Yes,Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M0 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M0 Pineoblastoma,50.0,Stage M0 Medulloblastoma,50.0
M2,Yes,Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M2 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M2 Pineoblastoma,50.0,Stage M2 Medulloblastoma,50.0
M3,Yes,Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M3 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M3 Pineoblastoma,50.0,Stage M3 Medulloblastoma,50.0
M4,Yes,Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2,50.0,Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2,50.0,Stage M4 Childhood Ependymoma by Toronto Guidelines v2,50.0,Stage M4 Pineoblastoma,50.0,Stage M4 Medulloblastoma,50.0
M5,Yes,Childhood Acute Megakaryoblastic Leukemia with NUP98-KDM5A,50.0,,0.0,,0.0,,0.0,,0.0
M6,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
M7,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
MALIGNANT FIBROUS HISTIOCYTOMA,Yes,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 2,65.0,Inflammatory Malignant Fibrous Histiocytoma NCI Grade 3,65.0,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 2,62.86,Storiform-Pleomorphic Malignant Fibrous Histiocytoma NCI Grade 3,62.86,Fibrous Histiocytoma,60.0
MALIGNANT PT,Yes,Malignant Vipoma,15.0,Malignant Gastrinoma,15.0,Malignant Somatostatinoma,15.0,Malignant Glioma,15.0,Malignant Pericarditis,15.0
MALIGNANT_FIBROUS_HISTIOCYTOMA,Yes,Histiocytoma,40.0,,0.0,,0.0,,0.0,,0.0
MASKED LOW HYPODIPLOID,Yes,Low-Hypodiploid B Acute Lymphoblastic Leukemia,12.0,Low Grade Glioma,10.0,Low Grade Astrocytoma,10.0,Low-CSD Melanoma,10.0,Low Grade Osteosarcoma,10.0
MBL,Yes,Malignant Vaginal Mixed Tumor Resembling Synovial Sarcoma,50.0,Uterine Corpus Tumor Resembling Ovarian Sex Cord Tumor,50.0,,0.0,,0.0,,0.0
MDS WITH EXCESS BLASTS-2,Yes,Myelodysplastic Syndrome with Excess Blasts,15.0,Childhood Myelodysplastic Syndrome with Excess Blasts,12.0,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,12.0,Refractory Anemia with Excess Blasts in Transformation,12.0,Myelodysplastic Syndrome with Low Blasts,7.5
MDS WITH MULTILINEAGE DYSPLASIA,Yes,Acute Myeloid Leukemia with Multilineage Dysplasia,12.0,Bladder Urothelial Dysplasia,10.0,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,10.0,Childhood Fibrous Dysplasia,10.0,Fibrous Dysplasia,10.0
MDS WITH SINGLE LINEAGE DYSPLASIA,Yes,"Myelodysplastic Syndrome, Unclassifiable, with Single Lineage Dysplasia",15.0,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,12.86,"Myelodysplastic Syndrome, Not Otherwise Specified with Single Lineage Dysplasia",11.25,Bladder Urothelial Dysplasia,7.5,Colon Adenoma with Severe Dysplasia,7.5
MDS/MPN WITH RING SIDEROBLASTS AND THROMBOCYTOSIS,Yes,Myelodysplastic Syndrome with Ring Sideroblasts,12.0,"Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis, Not Otherwise Specified",10.0,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,10.0,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,8.57,Ovarian Signet Ring Cell Carcinoma,6.0
"MDS/MPN, UNCLASSIFIABLE",Yes,"NK-Cell Lymphoma, Unclassifiable",10.0,"Myelodysplastic Syndrome, Unclassifiable",10.0,"Refractory NK-Cell Lymphoma, Unclassifiable",7.5,"Recurrent NK-Cell Lymphoma, Unclassifiable",7.5,Diffuse Large B-Cell Lymphoma Unclassifiable,6.0
MEDULLARY,Yes,Medullary Hemangioblastoma,65.0,Kidney Medullary Carcinoma,60.0,Breast Medullary Carcinoma,60.0,Colon Medullary Carcinoma,60.0,Rectal Medullary Carcinoma,60.0
MED_GROUP_3,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
MENINGOTHELIAL TUMOR,Yes,Metanephric Tumor,15.0,Krukenberg Tumor,15.0,Wolffian Tumor,15.0,Neuroendocrine Tumor,15.0,Neuroendocrine Tumor G1,15.0
METASTATIC CARCINOMA,Yes,Metastatic Carcinoma,100.0,Metastatic Carcinoma in the Rectum,70.0,Metastatic Carcinoma in the Pancreas,70.0,Metastatic Carcinoma in the Liver,70.0,Metastatic Carcinoma in the Lung,70.0
METASTATIC HORMONE-SENSITIVE,Yes,Metastatic Urothelial Carcinoma,10.0,Metastatic Cervical Carcinoma,10.0,Metastatic Cervical Adenocarcinoma,10.0,Metastatic Bladder Carcinoma,10.0,Metastatic Bladder Adenocarcinoma,10.0
"METASTATIC, VARIANT HISTOLOGY",Yes,Metastatic Urothelial Carcinoma,10.0,Metastatic Cervical Carcinoma,10.0,Metastatic Cervical Adenocarcinoma,10.0,Metastatic Bladder Carcinoma,10.0,Metastatic Bladder Adenocarcinoma,10.0
METATYPICAL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
MIT FAMILY TRANSLOCATION RENAL CELL CARCINOMA,Yes,Renal Cell Carcinoma,55.0,Carcinoma,45.0,Renal Cell Carcinoma with MiT Translocations,20.0,Childhood Renal Cell Carcinoma with MiT Translocations,20.0,Advanced Renal Cell Carcinoma,15.0
MIXED 80% ALVEOLAR,Yes,Mixed Glioma,15.0,Alveolar Adenoma,15.0,Alveolar Rhabdomyosarcoma,15.0,Mixed Liposarcoma,15.0,Mixed Carcinoma,15.0
MIXED ACINAR-NEUROENDOCRINE CARCINOMA,Yes,Neuroendocrine Carcinoma,55.0,Carcinoma,47.5,Pancreatic Mixed Acinar Carcinoma-Neuroendocrine Carcinoma,24.0,Pancreatic Mixed Acinar-Ductal Carcinoma,18.0,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,17.14
"MIXED PHENOTYPE ACUTE LEUKAEMIA, T/MYELOID, NOS",Yes,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",24.0,"Mixed Phenotype Acute Leukemia, B/Myeloid",24.0,"Mixed Phenotype Acute Leukemia, T/Myeloid",24.0,Refractory Mixed Phenotype Acute Leukemia,18.0,Recurrent Mixed Phenotype Acute Leukemia,18.0
"MIXED PHENOTYPE ACUTE LEUKEMIA, B/MYELOID, NOS",Yes,"Mixed Phenotype Acute Leukemia, B/Myeloid",70.0,Mixed Phenotype Acute Leukemia,64.0,Acute Leukemia,52.0,Leukemia,46.0,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",30.0
"MIXED PHENOTYPE ACUTE LEUKEMIA, T/MYELOID, NOS",Yes,"Mixed Phenotype Acute Leukemia, T/Myeloid",70.0,Mixed Phenotype Acute Leukemia,64.0,Acute Leukemia,52.0,Leukemia,46.0,"Mixed Phenotype Acute Leukemia, B/T/Myeloid",30.0
MIXED SEROUS AND ENDOMETRIOID,Yes,Paratesticular Serous Cystadenoma,10.0,Ovarian Endometrioid Adenofibroma,10.0,Ovarian Endometrioid Cystadenofibroma,10.0,Ovarian Endometrioid Cystadenoma,10.0,Ovarian Serous Cystadenoma,10.0
MLL-ALL,Yes,Mature T-ALL,15.0,Pre T-ALL,15.0,,0.0,,0.0,,0.0
MMMT,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
MULTIPLE MYELOMA,Yes,Multiple Myeloma,100.0,Refractory Multiple Myeloma,70.0,Recurrent Multiple Myeloma,70.0,Multiple Myeloma Myeloma by DS Stage,70.0,DS Stage I Multiple Myeloma,70.0
MULTIPLE_MYELOMA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
"MYELODYSPLASTIC/MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE",Yes,Myelodysplastic/Myeloproliferative Neoplasm,62.5,Myeloproliferative Neoplasm,55.0,Refractory Myelodysplastic/Myeloproliferative Neoplasm,22.5,Recurrent Myelodysplastic/Myeloproliferative Neoplasm,22.5,Myelodysplastic/Myeloproliferative Neoplasm with Isolated Isochromosome 17q,18.0
MYELOMA,Yes,Multiple Myeloma,65.0,Refractory Multiple Myeloma,60.0,Recurrent Multiple Myeloma,60.0,Multiple Myeloma Myeloma by DS Stage,60.0,DS Stage I Multiple Myeloma,60.0
NESTED STROMAL EPITHELIAL TUMOR OF THE LIVER,Yes,Calcifying Nested Stromal-Epithelial Tumor,24.0,Kidney Mixed Epithelial and Stromal Tumor,18.0,Benign Kidney Mixed Epithelial and Stromal Tumor,15.0,Malignant Mixed Epithelial and Stromal Tumor of the Kidney,15.0,Seminal Vesicle Mixed Epithelial and Stromal Tumor,15.0
NEUROTROPIC,Yes,Desmoplastic Neurotropic Melanoma,60.0,,0.0,,0.0,,0.0,,0.0
NKC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
NON-SEMINOMA,Yes,Intratubular Non-Seminoma,70.0,Testicular Non-Seminomatous Germ Cell Tumor,55.0,Seminoma,55.0,Malignant Testicular Non-Seminomatous Germ Cell Tumor,54.29,Childhood Testicular Non-Seminomatous Germ Cell Tumor,54.29
NORMAL-LIKE,Yes,Normal Breast-Like Subtype of Breast Carcinoma,12.0,Mesonephric-Like Adenocarcinoma,10.0,Kidney Oncocytoma-Like Angiomyolipoma,7.5,Vulvar Lipoblastoma-Like Tumor,7.5,Ovarian Mesonephric-Like Adenocarcinoma,7.5
NO_FUSION,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
NSCLC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
OV,Yes,Childhood Benign Ovarian Neoplasm,50.0,Childhood Ovarian Fibroma,50.0,Childhood Ovarian Sclerosing Stromal Tumor,50.0,Childhood Ovarian Mature Teratoma,50.0,Benign Ovarian Neoplasm,50.0
PAAD,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND,Yes,Carcinoma,45.0,Breast Papillary Ductal Carcinoma In Situ,15.0,Breast Papillary Ductal Carcinoma In Situ with Invasion,15.0,Childhood Thyroid Gland Papillary Carcinoma,15.0,Recurrent Thyroid Gland Papillary Carcinoma,15.0
PAPILLARY INFILTRATING DUCTAL CARCINOMA-MAMMARY GLAND; BREAST,Yes,Carcinoma,44.29,Breast Papillary Ductal Carcinoma In Situ,17.14,Breast Papillary Ductal Carcinoma In Situ with Invasion,17.14,Breast Ductal Carcinoma In Situ,12.86,"Breast Ductal Carcinoma In Situ, Comedo Type",12.86
"PAPILLARY, FOLLICULAR",Yes,Papillary Adenofibroma,15.0,Papillary Craniopharyngioma,15.0,Follicular Ameloblastoma,15.0,Papillary Ependymoma,15.0,Papillary Meningioma,15.0
PAST,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
PDA - MIXED DUCTAL ENDOCRINE CARCINOMA,Yes,Carcinoma,46.0,Breast Mixed Ductal and Lobular Carcinoma,18.0,Pancreatic Mixed Acinar-Ductal Carcinoma,18.0,Pancreatic Mixed Ductal Adenocarcinoma-Neuroendocrine Carcinoma,15.0,Pancreatic Mixed Ductal Adenocarcinoma-Acinar Carcinoma-Neuroendocrine Carcinoma,12.86
PDA - MUCINOUS NON-CYSTIC CARCINOMA,Yes,Carcinoma,46.0,Non-Invasive Pancreatic Mucinous-Cystic Neoplasm,15.0,Pancreatic Mucinous-Cystic Neoplasm with an Associated Invasive Carcinoma,12.86,Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma,12.86,Vaginal Adenoid Cystic Carcinoma,12.0
PENILE SQUAMOUS CELL CARCINOMA,Yes,Penile Squamous Cell Carcinoma,100.0,Metastatic Penile Squamous Cell Carcinoma,74.0,Unresectable Penile Squamous Cell Carcinoma,74.0,"Penile Squamous Cell Carcinoma, Usual Type",74.0,Locally Advanced Penile Squamous Cell Carcinoma,70.0
PERITONEAL MESOTHELIOMA,Yes,Peritoneal Malignant Mesothelioma,20.0,Peritoneal Sarcomatoid Mesothelioma,20.0,Peritoneal Biphasic Mesothelioma,20.0,Peritoneal Epithelioid Mesothelioma,20.0,Peritoneal Multicystic Mesothelioma,20.0
PERIVASCULAR EPITHELIOID CELL TUMOR,Yes,Epithelioid Cell Type Gastrointestinal Stromal Tumor,18.0,Juxtaglomerular Cell Tumor,15.0,Renomedullary Interstitial Cell Tumor,15.0,Benign Sertoli Cell Tumor,15.0,Juvenile Granulosa Cell Tumor,15.0
PFA,Yes,"Posterior Fossa Ependymoma, Group A (PFA)",56.0,,0.0,,0.0,,0.0,,0.0
PH-LIKEALL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
PITUITARY ADENOMA,Yes,Adenoma,55.0,Metanephric Adenoma,15.0,Kidney Adenoma,15.0,Prostate Adenoma,15.0,Vaginal Adenoma,15.0
PLASMA CELL MYELOMA,Yes,Plasma Cell Myeloma-Induced Bone Disease,65.0,Plasma Cell Leukemia,20.0,Plasma Cell Neoplasm,20.0,Refractory Plasma Cell Neoplasm,15.0,Recurrent Plasma Cell Leukemia,15.0
PLASMA_CELL_MYELOMA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
PLEURAL MESOTHELIOMA,Yes,Pleural Mesothelioma In Situ,70.0,Pleural Malignant Mesothelioma,20.0,Pleural Epithelioid Mesothelioma,20.0,Pleural Sarcomatoid Mesothelioma,20.0,Pleural Desmoplastic Mesothelioma,20.0
PLMESO,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
PNET,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
POORLY DIFFERENTIATED OR PLEOMORPHIC OR EPITHELIOID LEIOMYOSARCOMA,Yes,Epithelioid Leiomyosarcoma,52.0,Leiomyosarcoma,46.0,Sarcoma,40.0,Cervical Poorly Differentiated Adenosquamous Carcinoma,12.0,Poorly Differentiated Prostate Adenocarcinoma,12.0
PRAD,Yes,Ann Arbor Stage II Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma,50.0,Ann Arbor Stage I Supradiaphragmatic Nodular Lymphocyte Predominant B-Cell Lymphoma,50.0,Ann Arbor Stage I Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,50.0,Ann Arbor Stage II Supradiaphragmatic Lymphocyte-Depleted Classic Hodgkin Lymphoma,50.0,Ann Arbor Stage II Supradiaphragmatic Nodular Sclerosis Classic Hodgkin Lymphoma,50.0
PRE-T,Yes,Pre T-ALL,15.0,Pre-B Acute Lymphoblastic Leukemia,7.5,Pre-Pre-B Acute Lymphoblastic Leukemia,7.5,Adult Pre-B Acute Lymphoblastic Leukemia,6.0,Childhood Pre-B Acute Lymphoblastic Leukemia,6.0
PRIMARY CNS MELANOMA,Yes,Melanoma,50.0,Melanoma of Unknown Primary,20.0,Bladder Melanoma,10.0,Urethral Melanoma,10.0,Penile Mucosal Melanoma,10.0
PRO MYELOCYTIC LEUKEMIA,Yes,Leukemia,50.0,Testicular Leukemia,10.0,Meningeal Leukemia,10.0,Leukemia Cutis,10.0,Aleukemic Leukemia Cutis,10.0
RAEB,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
RARS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
RARS-T,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
RCMD,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
READ,Yes,Medulloblastoma with Leptomeningeal Spread,50.0,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",50.0,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",50.0,Superficial Spreading Adenocarcinoma,50.0,,0.0
READ_GS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
REFRACTORY ANEMIA WITH EXCESS BLASTS-2,Yes,Refractory Anemia,55.0,Refractory Anemia with Excess Blasts in Transformation,24.0,Myelodysplastic Syndrome with Excess Blasts,15.0,Childhood Myelodysplastic Syndrome with Excess Blasts,12.0,Myelodysplastic Syndrome with Excess Blasts and Fibrosis,12.0
REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA,Yes,Refractory Cytopenia of Childhood,15.0,Acute Myeloid Leukemia with Multilineage Dysplasia,12.0,Recurrent Acute Myeloid Leukemia with Multilineage Dysplasia,10.0,Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia,10.0,"Myelodysplastic Syndrome, Not Otherwise Specified with Multilineage Dysplasia",8.57
RENAL SPINDLE CELL CARCINOMA,Yes,Carcinoma,47.5,Advanced Renal Cell Carcinoma,22.5,Metastatic Renal Cell Carcinoma,22.5,Refractory Renal Cell Carcinoma,22.5,Recurrent Renal Cell Carcinoma,22.5
ROSAI-DORFMAN DISEASE,Yes,Rosai-Dorfman-Destombes Disease,22.5,Cutaneous Rosai-Dorfman-Destombes Disease,18.0,Bone Rosai-Dorfman-Destombes Disease,18.0,Thyroid Gland Rosai-Dorfman-Destombes Disease,15.0,Head and Neck Rosai-Dorfman-Destombes Disease,15.0
"ROUND CELL SARCOMA, OTHER",Yes,Sarcoma,50.0,Undifferentiated Round Cell Sarcoma,22.5,Mast Cell Sarcoma,20.0,Langerhans Cell Sarcoma,20.0,Spindle Cell Sarcoma,20.0
RT,Yes,Renal Pelvis Inverted Papilloma,50.0,Ureter Inverted Papilloma,50.0,Bladder Inverted Papilloma,50.0,Urethral Inverted Papilloma,50.0,Inverted Urothelial Papilloma,50.0
SARC LMS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SARC LS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SARCOMA LEIOMYO,Yes,Sarcoma,55.0,Vaginal Sarcoma,15.0,Ovarian Sarcoma,15.0,Vulvar Sarcoma,15.0,Prostate Sarcoma,15.0
SARC_DDLPS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SARC_LMS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SARC_OTHER,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SBS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SCCOHT,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SCHMINKE TUMOR/LYMPHOEPITHELIAL CARCINOMA,Yes,Carcinoma,47.5,Laryngeal Lymphoepithelial Carcinoma,15.0,Salivary Gland Lymphoepithelial Carcinoma,15.0,Sinonasal Lymphoepithelial Carcinoma,15.0,Lung Lymphoepithelial Carcinoma,15.0
"SEROUS BORDERLINE OVARIAN TUMOR, MICROPAPILLARY",Yes,Borderline Ovarian Serous Tumor,24.0,Borderline Ovarian Serous Tumor/Atypical Proliferative Ovarian Serous Tumor,20.0,Borderline Ovarian Serous Papillary Cystic Tumor,20.0,Borderline Ovarian Serous Surface Papillary Tumor,20.0,Benign Ovarian Serous Tumor,18.0
SEROUS_CARCINOMA,Yes,Carcinoma,40.0,,0.0,,0.0,,0.0,,0.0
SKCM,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SMALL CELL CARCINOMA OF UNKNOWN PRIMARY,Yes,Carcinoma of Unknown Primary,58.0,Carcinoma,46.0,Squamous Cell Carcinoma of Unknown Primary,24.0,Neck Squamous Cell Carcinoma of Unknown Primary,20.0,Vaginal Small Cell Neuroendocrine Carcinoma,18.0
SMOLDERING MYELOMA,Yes,Smoldering Multiple Myeloma,20.0,Multiple Myeloma,15.0,Refractory Multiple Myeloma,10.0,Recurrent Multiple Myeloma,10.0,Multiple Myeloma Myeloma by DS Stage,10.0
SOFT TISSUE MYOEPITHELIAL CARCINOMA,Yes,Carcinoma,47.5,Prostate Carcinoma Metastatic in the Soft Tissue,18.0,Cervical Soft Tissue Neoplasm,15.0,Vaginal Soft Tissue Neoplasm,15.0,Vulvar Soft Tissue Neoplasm,15.0
SPECIFIC_DX_AT_ACQUISITION_MDSMPN,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ST-RELPOS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
ST-YAP,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
STAD,Yes,Seminal Vesicle Cystadenoma,50.0,Paratesticular Serous Cystadenoma,50.0,Paratesticular Mucinous Cystadenoma,50.0,Epididymal Cystadenoma,50.0,Epididymal Papillary Cystadenoma,50.0
STAD_GS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
SUPERFICIAL SPREADING,Yes,Superficial Spreading Adenocarcinoma,70.0,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",60.0,Superficial Angiomyxoma,15.0,Superficial Fibromatosis,15.0,Vaginal Superficial Myofibroblastoma,10.0
SUPERFICIAL SPREADING MELANOMA,Yes,"Low-CSD Melanoma, Superficial Spreading Melanoma Subtype",65.0,Melanoma,50.0,Superficial Spreading Adenocarcinoma,20.0,Vaginal Superficial Myofibroblastoma,10.0,Vulvar Superficial Myofibroblastoma,10.0
SWEAT GLAND ADENOCARCINOMA,Yes,Adenocarcinoma,50.0,Carcinoma,40.0,Bartholin Gland Adenocarcinoma,20.0,Thyroid Gland Adenocarcinoma,20.0,Parotid Gland Adenocarcinoma,20.0
S_T_MDS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
"T-CELL, NON-HODGKINS, CUTANEOUS",Yes,Cutaneous Merkel Cell Carcinoma,15.0,Cutaneous Granular Cell Tumor,15.0,Cutaneous Mantle Cell Lymphoma,15.0,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,15.0
"T-CELL, NON-HODGKINS, CUTANEOUS, SEZARY SYNDROME",Yes,Sezary Syndrome,50.0,Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0,Primary Cutaneous B-Cell Non-Hodgkin Lymphoma,15.0,Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0,Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma,15.0
T-CELL_ALL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
TALL,Yes,Breast Tall Cell Carcinoma with Reversed Polarity,55.0,Tall Cell Variant Thyroid Gland Papillary Carcinoma,54.29,,0.0,,0.0,,0.0
TC:SCC,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
TGCT SEM,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
THCA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
THERAPY-RELATED MYELODYSPLASTIC SYNDROME,Yes,Myelodysplastic Syndrome,55.0,Epipodophyllotoxin-Related Myelodysplastic Syndrome,22.5,Myelodysplastic Syndrome Post Cytotoxic Therapy,18.0,Alkylating Agent-Related Myelodysplastic Syndrome,18.0,Refractory Myelodysplastic Syndrome,15.0
THERAPY-RELATED MYELOID NEOPLASMS,Yes,Myeloid Neoplasm,47.5,Therapy-Related Leukemia,15.0,Endometrioid Stromal and Related Neoplasms,15.0,Therapy-Related Neoplasm,15.0,Therapy-Related Malignant Neoplasm,15.0
THPA,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
THPD,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
THYMOMA; TYPE C,Yes,Thymoma,70.0,Thymoma Type B3,30.0,Thymoma Type A,30.0,Thymoma Type AB,30.0,Thymoma Type B,30.0
TRANSLOCATION-ASSOCIATED RENAL CELL CARCINOMA,Yes,Renal Cell Carcinoma,58.0,Carcinoma,46.0,Renal Cell Carcinoma Associated with Neuroblastoma,24.0,Renal Cell Carcinoma Associated with t(X;1)(p11.2;q21),20.0,Renal Cell Carcinoma Associated with t(X;1)(p11.2;p34),20.0
TYPE A,Yes,Bladder Enteric Type Adenocarcinoma,50.0,Breast Classic Lobular Carcinoma In Situ Type A,50.0,Parathyroid Gland Mixed Cell Type Adenoma,50.0,Colon Cribriform Comedo-Type Adenocarcinoma,50.0,Rectal Cribriform Comedo-Type Adenocarcinoma,50.0
TYPE C,Yes,Type C Lymphomatoid Papulosis,50.0,,0.0,,0.0,,0.0,,0.0
T_CELL_ALCL,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
UCEC ENDO,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
UCS,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
UM,Yes,Ossifying Renal Tumor of Infancy,50.0,Childhood Ovarian Sclerosing Stromal Tumor,50.0,Urethral Condyloma Acuminatum,50.0,Metanephric Tumor,50.0,Metanephric Stromal Tumor,50.0
UNCLASSIFIED RENAL CELL CARCINOMA,Yes,Renal Cell Carcinoma,62.5,Carcinoma,47.5,Advanced Renal Cell Carcinoma,22.5,Metastatic Renal Cell Carcinoma,22.5,Refractory Renal Cell Carcinoma,22.5
UNKNOWN TUMOR,Yes,Metanephric Tumor,15.0,Krukenberg Tumor,15.0,Wolffian Tumor,15.0,Neuroendocrine Tumor,15.0,Neuroendocrine Tumor G1,15.0
URACHAL ADENOCARCINOMA,Yes,Urachal Adenocarcinoma,100.0,Adenocarcinoma,55.0,Carcinoma,40.0,Vaginal Adenocarcinoma,15.0,Mesonephric Adenocarcinoma,15.0
URACHAL CARCINOMA,Yes,Urachal Carcinoma,100.0,Carcinoma,55.0,Urachal Urothelial Carcinoma,20.0,Metastatic Urachal Urothelial Carcinoma,15.0,Vaginal Carcinoma,15.0
UTERINE PERIVASCULAR EPITHELIOID CELL TUMOR,Yes,Uterine Corpus Germ Cell Tumor,18.0,Epithelioid Cell Type Gastrointestinal Stromal Tumor,18.0,Benign Epithelioid Cell Type Gastrointestinal Stromal Tumor,15.0,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,15.0,Juxtaglomerular Cell Tumor,12.0
UVM,Yes,,0.0,,0.0,,0.0,,0.0,,0.0
